Preclinical experiments advise that retatrutide may possibly impact weight problems-associated cancer progression. In the analyze led by Marathe et al., retatrutide-induced fat loss minimized tumor engraftment, delayed tumor onset, and significantly attenuated tumor development in pancreatic and lun